West Pharmaceutical Services, Inc. ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für West Pharmaceutical Services, Inc. zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um West Pharmaceutical Services, Inc. zu Deinem Portfolio hinzuzufügen.
EXTON, Pa. , Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™ Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system marks a significant shift in drug delivery solutions by offering a fully verified p...
EXTON, Pa. , Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: UBS Global Healthcare Conference: Fireside chat at 9:30 AM ET on Tuesday, November 11, 2025, in Palm Beach Gardens, FL. Jefferies Global Healthc...
It was a beat-and-raise third quarter for the healthcare services specialist. It experienced broad growth throughout its product and service offerings.
West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants John Sweeney - Head of Investor Relations Eric Green - Non-Independent Chair of the Board, President & CEO Robert McMahon - Senior VP & CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Inc., Research Division Michael Ryskin - BofA Securities, Research Divi...
Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after posting better-than-expected results for the third quarter, banking on strong demand for its components used in GLP-1 weight-loss and diabetes drugs.
West Pharmaceutical Services earns a Buy rating with a $320 price target, reflecting ~18% upside with strong long-term growth prospects. WST's high-value product mix is expanding, driving margin growth through proprietary, high-margin offerings and regulatory stickiness. Surging demand for GLP-1 therapies and biologics underpins durable growth for WST's containment and delivery systems, reinfor...
EXTON, Pa. , Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 23, 2025, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Easter...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.